Early‐onset familial parkinsonism due to <i>POLG</i> mutationsGuido Davidzon, Salvatore DiMauro, J. Eric Ahlskog et al.|Annals of Neurology|2006Cited by 236
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trialAndrew McGarry, Karl Kieburtz, Shane Rosanbalm et al.|The Lancet Neurology|2023Cited by 128